• 1
    Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377383.
  • 2
    Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M et al. Trends in serum lipids and lipoproteins of adults, 1960–2002. JAMA 2005;294:17731781.
  • 3
    Kimata H. Cholesterol selectively enhances in vitro latex-specific Ige production in atopic dermatitis patients with latex allergy. Life Sci 2005;76:15271532.
  • 4
    Pesonen M, Ranki A, Siimes MA, Kallio MJ. Serum cholesterol level in infancy is inversely associated with subsequent allergy in children and adolescents. A 20-year follow-up study. Clin Exp Allergy 2008;38:178184.
  • 5
    Schafer T, Ruhdorfer S, Weigl L, Wessner D, Heinrich J, Doring A et al. Intake of unsaturated fatty acids and Hdl cholesterol levels are associated with manifestations of atopy in adults. Clin Exp Allergy 2003;33:13601367.
  • 6
    Yeh YF, Huang SL. Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation. J Biomed Sci 2004;11:599606.
  • 7
    Ouyang F, Kumar R, Pongracic J, Story RE, Liu X, Wang B et al. Adiposity, serum lipid levels, and allergic sensitization in Chinese men and women. J Allergy Clin Immunol 2009;123:940948 e10.
  • 8
    Davidson MH. Is Ldl-C passed its prime? The emerging role of non-Hdl, Ldl-P, and Apob in Chd risk assessment. Arterioscler Thromb Vasc Biol 2008;28:15821583.
  • 9
    Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008;118:9931001.
  • 10
    Visness CM, London SJ, Daniels JL, Kaufman JS, Yeatts KB, Siega-Riz AM et al. Association of obesity with Ige levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol 2009;123:11631169, 9 e1–4.
  • 11
    Parish S, Peto R, Palmer A, Clarke R, Lewington S, Offer A et al. The joint effects of apolipoprotein B, apolipoprotein A1, Ldl cholesterol, and Hdl cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J 2009;30:21372146.
  • 12
    McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the Interheart Study): a case-control study. Lancet 2008;372:224233.
  • 13
    Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR. The relationship between oxidized Ldl and other cardiovascular risk factors and subclinical Cvd in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;194:245252.
  • 14
    Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002;5:153158.
  • 15
    Coward W, Chow SC. Effect of atorvastatin on Th1 and Th2 cytokine secreting cells during T cell activation and differentiation. Atherosclerosis 2006;186:302309.
  • 16
    Fessler MB, Massing MW, Spruell B, Jaramillo R, Draper DW, Madenspacher JH, et al. Novel relationship of serum cholesterol with asthma and wheeze in the United States. J Allergy Clin Immunol 2009;124:967974.
  • 17
    Srinivasan SR, Li S, Chen W, Tang R, Bond MG, Boerwinkle E et al. Q192r polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a Biracial community. The Bogalusa Heart Study. Atherosclerosis 2004;177:167174.